Review
Copyright ©The Author(s) 2020.
World J Gastroenterol. Oct 7, 2020; 26(37): 5561-5596
Published online Oct 7, 2020. doi: 10.3748/wjg.v26.i37.5561
Table 1 Summary of the randomised controlled trials on early (preemptive) transjugular intrahepatic portosystemic shunt
Ref.No. of pts (TIPS/control)Primary inclusion criteriaPrimary and secondary end-pointsRebleeding (%; TIPS/control)1-yr survival (%; TIPS/control)HE (%; TIPS/control)
Monescillo et al[13]26/26HVPG > 20 mmHgPrimary: sensivity and specificity of HVPG cutoff value (20 mmHg) in predicting TFS, and assessment of TFS as well as short- and long-term survival; secondary: transfusional needs, ICU stay, complications during the first week of treatment, and causes of death12/5062/3531/35
Garcia-Pagán et al[14]32/31Child–Pugh class C disease (a score of 10 to 13) or class B disease but with active bleeding at diagnostic endoscopyPrimary: failure to control bleeding and failure to prevent clinically significant variceal rebleeding within 1 yr; secondary: mortality at 6 wk and at 1 yr, failure to control acute bleeding, early rebleeding, rate of rebleeding between 6 wk and 1 yr, other complications of portal hypertension, the number of days in the ICU, days spent in the hospital, and the use of alternative treatments3/5086/6125/39
Lv et al[20]84/45Child–Pugh class C disease (a score of 10 to 13) or class B disease (with or without active bleeding at diagnostic endoscopy)Primary: TFS; secondary: failure to control bleeding or rebleeding, new or worsening ascites, overt HE, and other complications of portal hypertension11/3462/3535/36
Dunne et al[21]29/29Child–Pugh class C disease (a score of 10 to 13) or class B disease (with or without active bleeding at diagnostic endoscopy); inability to control bleeding at index endoscopy was considered an exclusion criteriaPrimary: 1-yr survival; secondary: survival at 6 wk, early rebleeding (within 6 wk) and late rebleeding (between 6 wk and 1 yr), and the development of HE24/3479/7641/17